切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2008, Vol. 02 ›› Issue (01) : 24 -27. doi: 10.3877/cma.j.issn.1674-0807.2008.01.007

临床研究

乳腺小黏蛋白在检测乳腺癌患者外周血微转移中的意义
仲雷1, 张建国1, 郭宝良1, 杨学伟1, 单明1   
  1. 1.150086 哈尔滨,哈尔滨医科大学附属二院乳腺外科
  • 收稿日期:2007-09-07 出版日期:2008-02-01
  • 基金资助:
    国家自然科学基金资助项目(30672420)黑龙江省科技厅攻关项目(GB05C402-01)

Detection of SBEM-mRNA level in peripheral blood of patients with breast cancer and its clinical significance

Lei ZHONG1, Jian-guo ZHANG1, Bao-liang GUO1, Xue-wei YANG1, Ming SHAN1   

  1. 1.Department of Breast Surgery,Second Affiliated Hospital of Harbin Medical College,Harbin 150086,China
  • Received:2007-09-07 Published:2008-02-01
引用本文:

仲雷, 张建国, 郭宝良, 杨学伟, 单明. 乳腺小黏蛋白在检测乳腺癌患者外周血微转移中的意义[J/OL]. 中华乳腺病杂志(电子版), 2008, 02(01): 24-27.

Lei ZHONG, Jian-guo ZHANG, Bao-liang GUO, Xue-wei YANG, Ming SHAN. Detection of SBEM-mRNA level in peripheral blood of patients with breast cancer and its clinical significance[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2008, 02(01): 24-27.

目的

探讨乳腺小黏蛋白(small breast epithelial mucin,SBEM)mRNA 作为检测乳腺癌患者外周血微转移指标的临床意义。

方法

用巢式逆转录-聚合酶链反应(Nested-RT-PCR)法检测22 例女性胃癌、16 例结/直肠癌、107 例乳腺癌、40 例乳腺纤维腺瘤患者和27 例健康志愿者外周血中SBEM-mRNA 的表达情况。

结果

107 例乳腺癌患者外周血中SBEM-mRNA 有57 例表达,阳性率为53.27%,其余对照组中SBEM-mRNA 表达均为阴性。 两组比较差异有统计学意义(P <0. 05)。SBEM-mRNA 的阳性表达与患者的淋巴结转移状况和TNM 分期均有相关性(P 均<0.01);而与患者的年龄、原发肿瘤大小、病理类型、ER、PR 等无相关性(P >0.05)。

结论

SBEM-mRNA 特异表达于乳腺癌患者的外周血,可能成为检测乳腺癌患者外周血中微转移和判断预后的指标之一。

Objective

To evaluate the clinical significance of SBEM (small breast epithelial mucin) mRNA as a micrometastases marker in peripheral blood of breast cancer.

Methods

The SBEMmRNA level in peripheral blood was detected in 22 patients with gastric cancer,16 colon/rectal carcinoma,107 breast cancer,40 breast fibroadenoma and 27 healthy volunteers as controls using rested reverse transcription-polymerase chain reaction (Nested-RT-PCR).

Results

The positive expression rate of SBEMmRNA in peripheral blood of breast cancer patients was 53.27%(57/107 cases),and no positive SBEMmRNA was found in other controls.There was a significant difference between the two groups (P <0.05).SBEM-mRNA expression was correlated with axillary lymph nodes status and TNM (P <0. 01), but uncorrelated with other clinical parameters (age,tumor size,histopathlogy types,estrogen receptor and progesterone receptor).

Conclusion

SBEM-mRNA is sensitive and specific for breast cancer,and the positive expression in peripheral blood may be a marker in detecting micrometastases and judging prognosis.

表1 SBEM-mRNA 在乳腺癌、乳腺纤维腺瘤及健康人外周血的表达
表2 女性不同恶性肿瘤患者外周血SBEM-mRNA 的表达情况
表3 SBEM-mRNA 在乳腺癌外周血的表达情况与临床病理学特征的关系
[1]
Parker S L,Tong T,Bolden S,et al. Cancer statistics 1997. CA Cancer J Clin,1997,47:5-27.
[2]
Bundred N J.Prognostic and predictive factors in breast cancer.Cancer Treat Rev,2001,27:137-142.
[3]
Fisher B. Personal contributions to progress in breast cancer research and treatment.Semin Oncol,1996,23:414-427.
[4]
张嘉庆,王殊,乔新民.乳腺癌的现状与远景.中华外科杂志,2002,40:161-163.
[5]
Grunewald K,Haun M,Urbanek M,et al. Mammaglobin gene express:a superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19.Lab Invest,2000,80:1071-1077.
[6]
Zhu L,Lam C K,Chow L W. Sentinel lymph node biopsy or detection of micrometastasis in bone marrow:which might be an alternative to axillary lymph node dissection in breast cancer patients.Asian J Surg,2004,27:279-283.
[7]
Gardner B,Feldman J.Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg,1993,218:270-275.
[8]
Miksicek R J,Myal Y,Watson P H,et al.Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium.Cancer Res,2002,62:2736-2740.
[9]
Ghossein R A,Rosai J. The polymerase chain reaction in the detection of micrometastases and circulating tumor cells:present status and future potential.Anat Pathol,1998,3:233-51.
[10]
Zach O,Kasparu H,Krieger O,et al. Detection of circulating mammary carcinima cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA.J Clin Oncol,1999,17:2015-2019.
[11]
Raj G V,Moreno J G,Gomella L G. Utilization of polymerase chain reaction technology in the detection of solid tumors.Cancer,1998,82:1419-1442.
[12]
耿强,王水,范萍,等.乳腺癌前哨淋巴结和骨髓和外周血微小转移的联合检测.肿瘤防治杂志,2005,2:85-88.
[13]
陈兵,王云海.胃癌患者外周血肿瘤细胞的检测及其临床意义.中华医学实践杂志,2004,3:509-511.
[1] 洪玮, 叶细容, 刘枝红, 杨银凤, 吕志红. 超声影像组学联合临床病理特征预测乳腺癌新辅助化疗完全病理缓解的价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 571-579.
[2] 刘伟, 牛云峰, 安杰. LINC01232 通过miR-516a-5p/BCL9 轴促进三阴性乳腺癌的恶性进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 330-338.
[3] 杨柳, 宋振川, 王新乐. 乳腺癌改良根治术联合背阔肌复位的临床疗效评估[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(05): 269-273.
[4] 宋佳, 汪波, 孙凯律, 商江峰, 吴旦平, 肇毅. 吲哚菁绿荧光显影联合亚甲蓝染色在乳腺癌前哨淋巴结活检中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 498-501.
[5] 张钊, 骆成玉, 张树琦, 何平, 李旭斌. 不同术式治疗早期乳腺癌的效果及并发症发生率、复发率比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 494-497.
[6] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[7] 唐丹萍, 王萍, 江孟蝶, 杨晓蓉. 自体脂肪移植在乳腺癌术后乳房重建的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 582-585.
[8] 黄程鑫, 陈莉, 刘伊楚, 王水良, 赖晓凤. OPA1 在乳腺癌组织的表达特征及在ER阳性乳腺癌细胞中的生物学功能研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 275-284.
[9] 刘琦, 王守凯, 王帅, 苏雨晴, 马壮, 陈海军, 司丕蕾. 乳腺癌肿瘤内微生物组的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 841-845.
[10] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[11] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[12] 王帅, 张志远, 苏雨晴, 李雯雯, 王守凯, 刘琦, 李文涛. 孟德尔随机化及其在乳腺癌研究中的应用进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 671-676.
[13] 张梦婷, 穷拉姆, 色珍, 李逸群, 德庆旺姆. 西藏地区藏族乳腺癌新辅助化疗的真实世界研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 441-446.
[14] 赵阳, 肖迎聪, 巨艳, 党晓智, 蔡林利, 薛文欣, 李洋, 肖瑶, 郭妤绮, 宋宏萍. 基于自动乳腺超声的列线图模型早期预测HER-2阳性乳腺癌新辅助化疗病理完全缓解的临床价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 355-362.
[15] 黄宏山, 陈成彩. 经淋巴管超声造影在乳腺癌前哨淋巴结诊断中的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(04): 411-414.
阅读次数
全文


摘要